VeeralShethMDMBA, FACS
Ophthalmology • Oak Forest, ILGlaucoma Related, Retinal Disease, Uveitis
Physician and Surgeon Clinical Assistant Professor, University of Illinois at Chicago
Dr. Sheth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6320 159th St
Ste A
Oak Forest, IL 60452Phone+1 708-687-2222Fax+1 708-687-3829- Is this information wrong?
Education & Training
Northwestern University (Kellogg)MBA, 2012 - 2014
University of ChicagoFellowship, Surgical Retina and Vitreous, 2010
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 2004 - 2008- West Suburban Medical CenterInternship, Transitional Year, 2004 - 2005
- University of Illinois College of MedicineClass of 2004
Certifications & Licensure
IL State Medical License 2007 - 2026- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (FAAO) American Academy of Ophthalmology
- Join now to see all
Clinical Trials
- Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD Start of enrollment: 2005 Jun 01
- Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) Start of enrollment: 2006 Apr 01
- Age-Related Eye Disease Study 2 (AREDS2) Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Quantifying Fluid and Function in Suboptimal Responders Switched From an Anti-vascular Endothelial Growth Factor (VEGF) to Faricimab.Abigail Anderson, Sheila Wheatley, Veeral Sheth, Sutter, D., David Sutter> ;Cureus. 2024 Mar 1
- Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabeti...Guymer, R., Bailey, C., Chaikitmongkol, V., Chakravarthy, U., Chaudhary, V., Finger, R., Gallego-Pinazo, R., Chuan, A., Ishida, S., Lövestam-Adrian, M., Parravano, M.,...> ;Ophthalmology Science. 2023 Dec 3
- 3 citationsEfficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.Mark R Barakat, Michael S Ip, Charles C Wykoff, David A Eichenbaum, Sunir Joshi, David Warrow, Veeral S Sheth, Jana Stefanickova, Yong Soo Kim, Fanyin He, Ga Eun Cho, ...> ;JAMA Ophthalmology. 2023 Dec 1
- Join now to see all
Books/Book Chapters
Press Mentions
Ocuphire Pharma Announces Presentation on APX3330 at the Annual Angiogenesis, Exudation, and Degeneration 2024 ConferenceFebruary 6th, 2024
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish, Gujarati
Hospital Affiliations
Advocate Christ Medical CenterOak Lawn, Illinois- Silver Cross HospitalNew Lenox, Illinois
UChicago Medicine AdventHealth BolingbrookBolingbrook, Illinois- Advocate Good Samaritan HospitalDowners Grove, Illinois
University of Illinois HospitalChicago, Illinois
AMITA Health Adventist Medical Center - HinsdaleHinsdale, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
